2015 Literature Review On Demand

You can earn up to 7.25 AMA PRA Category 1 Credit(s). Cost: $145 $75 for College Members, $215 $109 for non-members.

This collection will help you keep abreast of the latest clinical developments in allergy and immunology, ACAAI will continue its highly successful Literature Review program. It’s a review of the most important, clinically focused literature of our specialty published between October 2014 and August 2015, with emphasis on clinical relevance. Faculty includes allergy/immunology training program directors and specialists in practice.


Release Date: 12/15/2015
Expiration Date: 12/14/2018


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

• Discuss recent developments in basic immunology in relation to allergic disorders

• Describe recent developments in infections diseases, antimicrobials, and vaccines

• Discuss recent developments in clinical immunology

• Better diagnose and manage asthma and COPD

• Discuss important scientific and clinical advances in the pathophysiology and treatment of urticaria, angioedema, and other skin disorders

• Apply practical lessons learned from recent literature in pediatric allergy, asthma and immunology

• Identify new concepts in anaphylaxis, drug allergy and stinging insect hypersensitivity, as well as utilize clinically relevant findings in these areas

• Describe recent developments in immunotherapy

• Discuss recent developments in food and additives allergy

• Better counsel patients on environmental factors that may impact respiratory and allergic disease, and better recognize, diagnose and manage occupational allergic diseases

• Describe recent developments in rhinitis and sinusitis

• Apply practical lessons learned from recent literature in allergy, asthma and immunology

Additional information

Mitchell H. Grayson, MD, FACAAI -- Supported/Contracted Research: Polyphor

Chitra Dinakar, MD, FACAAI -- Consultant/Advisor: Aerocrine; Supported/Contracted Research: GlaxoSmithKline, Merck, Teva

Marc A. Riedl, MD, MS -- Consultant/Advisor: Baxter, BioCryst, CSL Behring, Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax, Salix, Shire: Supported/Contracted Research: Amgen, Biocryst, CSL Behring, Dyax, Shire 

Anthony Montanaro, MD, FACAAI -- Supported/Contracted Research: Circassia, Genentech, GlaxoSmithKline, Merck, Teva

David A. Khan, MD, FACAAI -- Speaker: Baxter, Genentech

Harold S. Nelson, MD, FACAAI -- Consultant/Advisor: AstraZeneca, Circassia, Merck, Pearl Therapeutics; Supported/Contracted Research: Circassia

Matthew Greenhawt, MD, MBA, MSc, FACAAI -- Consultant/Advisor: National Peanut Board; Supported/Contracted Research: National Center for Translational Sciences 

Mark S. Dykewicz, MD, FACAAI -- Consultant/Advisor: Merck; Supported/Contracted Research: Novartis

Anju T. Peters, MD -- Consultant/Advisor: Baxter, Greer, Meda; Speaker: Celgene


The following have no financial relationships to disclose:

James T. Li, MD, PhD, FACAAI

John M. Routes, MD, FACAAI

John M. Kelso, MD, FACAAI

Course summary
Available credit: 
  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 Attendance
Course opens: 
Course expires: 

Available Credit

  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 Attendance


Please login or create an account to take this course.